Welcome to Dermbits! Watch short videos of KOLs answering your questions

thumbnail_dermbits-colorful.png

dermbits-colorful.png

Dermbits

Are there any head-to-head studies that look at the efficacy of topical ruxolitinib cream compared to a topical steroid?

Atopic Dermatitis

You. So there was a phase two study that was head to head with topical ruxalitinib cream, 1.5% twice a day for eight weeks. And it was compared to triumphinolone cream, zero, 1% that was given for four weeks. And then patients went on the vehicle. And what they showed was that there were similar result. The easy score. So, given the alternative of using topical steroids, which can produce hypopigmentation, atrophy of the skin, we have a different cream, ruxalivinib cream, that doesn't have those potential side effects.